Stockreport

Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights [Yahoo! Finance]

Avidity Biosciences, Inc.  (RNA) 
PDF Avidity to report FSHD data from FORTITUDE ™ trial this quarter and DMD data from EXPLORE44 ™ trial in 2H24 Presented positive long-term del-desiran data from MARINA- [Read more]